bims-tremylTherapy resistance biology in myeloid leukemia

Maintained by Paolo Gallipoli, Barts Cancer Institute, Queen Mary University of London.

2021‒10‒10
2021‒10‒03
2021‒09‒26
2021‒09‒19
2021‒09‒12
2021‒09‒05
2021‒08‒29
2021‒08‒22
2021‒08‒15
2021‒08‒08
2021‒08‒01
2021‒07‒25
2021‒07‒18
2021‒07‒11
2021‒07‒04
2021‒06‒27
2021‒06‒20
2021‒06‒13
2021‒06‒06
2021‒05‒30
2021‒05‒23
2021‒05‒16
2021‒05‒09
2021‒05‒02
2021‒04‒25
2021‒04‒18
2021‒04‒11
2021‒04‒04
2021‒03‒28
2021‒03‒21
2021‒03‒14
2021‒03‒07
2021‒02‒28
2021‒02‒21
2021‒02‒14
2021‒02‒07
2021‒01‒31
2021‒01‒24
2021‒01‒17
2021‒01‒10
2021‒01‒03
2020‒12‒27
2020‒12‒20
2020‒12‒13
2020‒12‒06
2020‒11‒29
2020‒11‒22
2020‒11‒15
2020‒11‒08
2020‒11‒01
2020‒10‒25
2020‒10‒18
2020‒10‒11
2020‒10‒04
2020‒09‒27
2020‒09‒20
2020‒09‒13
2020‒09‒06
2020‒08‒30
2020‒08‒23
2020‒08‒16
2020‒08‒09
2020‒08‒02
2020‒07‒26
2020‒07‒19
2020‒07‒12
2020‒07‒05
2020‒06‒28
2020‒06‒21